Oncoclinicas do Brasil (SA:ONCO3) — Stock Price
Oncoclinicas do Brasil (SA:ONCO3) is currently trading at R$0.56 BRL, down 9.68% today. Over the past 52 weeks, shares have ranged between R$0.55 and R$5.48. This page tracks Oncoclinicas do Brasil's live share price on the SA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ONCO3 market cap.
Oncoclinicas do Brasil (ONCO3) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Oncoclinicas do Brasil's daily closing share price and trading volume on the SA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Oncoclinicas do Brasil Income Statement — Revenue, Profit & Earnings by Year
Oncoclinicas do Brasil's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | R$6.23 Billion | R$5.49 Billion | R$4.09 Billion | R$2.70 Billion | R$2.04 Billion |
| Cost of Revenue | R$4.17 Billion | R$3.56 Billion | R$2.64 Billion | R$1.83 Billion | R$1.40 Billion |
| Gross Profit | R$2.06 Billion | R$1.93 Billion | R$1.45 Billion | R$868.79 Million | R$635.68 Million |
| Research & Development | — | R$37.00K | — | — | — |
| SG&A | R$1.40 Billion | R$1.17 Billion | R$980.82 Million | R$688.05 Million | R$603.61 Million |
| Total Operating Expenses | R$2.18 Billion | R$1.17 Billion | R$981.54 Million | R$691.58 Million | R$616.06 Million |
| Operating Income | R$-119.95 Million | R$758.02 Million | R$470.56 Million | R$177.22 Million | R$32.07 Million |
| EBITDA | R$271.24 Million | R$1.12 Billion | R$693.16 Million | R$343.67 Million | R$148.36 Million |
| EBIT | R$-55.14 Million | R$862.31 Million | R$518.01 Million | R$216.70 Million | R$41.55 Million |
| Interest Expense | R$601.71 Million | R$559.79 Million | R$433.13 Million | R$154.36 Million | R$94.80 Million |
| Income Before Tax | R$-656.86 Million | R$302.52 Million | R$121.54 Million | R$62.34 Million | R$-53.26 Million |
| Income Tax Expense | R$60.57 Million | R$-10.04 Million | R$7.77 Million | R$84.75 Million | R$68.09 Million |
| Net Income | R$-646.19 Million | R$223.62 Million | R$46.26 Million | R$-46.90 Million | R$-157.69 Million |
Oncoclinicas do Brasil Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Oncoclinicas do Brasil's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | R$11.20 Billion | R$9.18 Billion | R$8.22 Billion | R$6.03 Billion | R$3.39 Billion |
| Total Current Assets | R$4.66 Billion | R$3.11 Billion | R$2.83 Billion | R$2.87 Billion | R$1.43 Billion |
| Cash & Equivalents | R$472.62 Million | R$491.69 Million | R$217.56 Million | R$488.25 Million | R$724.14 Million |
| Short-term Investments | R$1.34 Billion | R$210.72 Million | R$829.59 Million | R$1.48 Billion | R$46.21 Million |
| Net Receivables | R$2.05 Billion | R$1.86 Billion | R$1.38 Billion | R$666.15 Million | R$993.09 Million |
| Inventory | R$225.24 Million | R$206.39 Million | R$163.94 Million | R$69.33 Million | R$37.07 Million |
| Property, Plant & Equipment | R$1.34 Billion | R$1.24 Billion | R$1.09 Billion | R$727.55 Million | R$624.51 Million |
| Goodwill | R$2.40 Billion | R$2.67 Billion | R$2.57 Billion | R$1.17 Billion | R$602.40 Million |
| Total Liabilities | R$7.82 Billion | R$6.50 Billion | R$5.59 Billion | R$3.73 Billion | R$2.71 Billion |
| Total Current Liabilities | R$2.45 Billion | R$1.82 Billion | R$1.88 Billion | R$1.19 Billion | R$1.02 Billion |
| Long-term Debt | R$4.16 Billion | R$3.74 Billion | R$2.77 Billion | R$1.80 Billion | R$1.16 Billion |
| Net Debt | R$4.93 Billion | R$4.00 Billion | R$3.21 Billion | R$1.89 Billion | R$891.44 Million |
| Total Stockholder Equity | R$3.15 Billion | R$2.30 Billion | R$2.12 Billion | R$1.85 Billion | R$401.77 Million |
| Retained Earnings | R$-711.06 Million | R$-64.87 Million | R$-288.49 Million | R$-334.75 Million | R$-287.85 Million |
Oncoclinicas do Brasil Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Oncoclinicas do Brasil generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | R$-184.85 Million | R$-51.56 Million | R$-271.64 Million | R$-9.28 Million | R$97.56 Million |
| Capital Expenditures | R$214.25 Million | R$311.69 Million | R$304.18 Million | R$201.94 Million | R$204.80 Million |
| Free Cash Flow | R$-399.10 Million | R$-363.26 Million | R$-575.82 Million | R$-211.23 Million | R$-107.24 Million |
| Investing Cash Flow | R$-1.72 Billion | R$227.83 Million | R$-408.72 Million | R$-2.03 Billion | R$-355.13 Million |
| Financing Cash Flow | R$1.91 Billion | R$111.42 Million | R$407.08 Million | R$1.83 Billion | R$551.12 Million |
| Dividends Paid | R$-11.66 Million | R$-59.71 Million | R$18.29 Million | R$26.40 Million | R$45.22 Million |
| Stock-Based Compensation | R$27.65 Million | R$46.84 Million | R$125.21 Million | R$-377.00K | R$13.36 Million |
| Depreciation | R$326.38 Million | R$257.37 Million | R$175.15 Million | R$126.97 Million | R$106.81 Million |
| Change in Cash | R$40.00K | R$287.50 Million | R$-273.63 Million | R$-204.05 Million | R$293.44 Million |
Oncoclinicas do Brasil Earnings History — EPS Actual vs. Analyst Estimates
Track Oncoclinicas do Brasil's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 13, 2026 | — | — | — |
| Mar 26, 2026 | — | — | — |
| Nov 14, 2025 | -0.15 | -0.07 | -114.29% |
| Aug 14, 2025 | -0.17 | -0.08 | -112.50% |
| May 15, 2025 | -0.23 | 0.03 | -866.67% |
| Dec 31, 2024 | — | 0.04 | — |
| Nov 13, 2024 | 0.02 | 0.08 | -75.00% |
| Aug 13, 2024 | 0.05 | 0.05 | +0.00% |